-
-
Call more information
660-596-2224 -
AUTHORS: Gurunathan, Usha FANZCA et al Anesthesia & Analgesia 138(4):p 763-774, April 2024. BACKGROUND: There is limited evidence to inform the association between the intake of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) and intraoperative blood pressure (BP) changes in an ambulatory surgery population. METHODS: Adult patients who underwent ambulatory surgery and were discharged on […]
Read MoreAuthor: Kelly Wolfgang ASA Monitor April 2024, Vol. 88, 27. Emerging evidence suggests that patients who suffer hip fractures and other traumatic injuries are at risk of prolonged opioid use when inadequate analgesia occurs. For anesthesiologists, proper acute pain management is imperative, from preoperative patient assessment to the postoperative recovery stage. Uncontrolled pain can be detrimental, […]
Read MoreAuthor: Patsy Newitt Becker’s Physician Leadership The anesthesia provider shortage is a continuing obstacle in care provision, as reimbursements decline, and physicians leave the workforce. Here are five key numbers on the anesthesia provider shortage to know: 1. Nearly 30% of anesthesiologists are predicted to leave the practice by 2033, according to a 2023 white paper from Medicus Healthcare […]
Read MoreAuthors: Andrew King, MD, MS et al ASA Monitor April 2024, Vol. 88, 33. A family history of deaths under general anesthesia – an unlikely nightmare for the modern anesthesiologist. But for Dr. Jim Villiers, that was a challenge he had to face for his patient in 1960s Melbourne, Australia. Malignant hyperthermia (MH), a topic […]
Read MoreASA Monitor April 2024, Vol. 88, 14. Unique approval for neuromuscular disorder treatment The U.S. Food and Drug Administration (FDA) has granted approval for Takeda’s Gammagard Liquid® as an intravenous immunoglobulin (IVIG) therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a rare immune-mediated neuromuscular disorder, and Gammagard Liquid is now the only IVIG therapy […]
Read More